Skip to main content
Log in

Anti-iodothyronine autoantibodies in a girl with hyperthyroidism due to pituitary resistance to thyroid hormones

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

In the present study, we report the uncommon case of a 9.6-yr-old girl with circulating an-ti-T3 autoantibodies (T3-Ab) and hyperthyroidism due to inappropriate secretion of TSH (IST). The diagnosis of IST was based on the findings of normal TSH levels (2.4 mU/L) in the presence of high free T4 (28.2 pmol/L) and free T3 (FT3) levels, as measured by direct measurement methods based on “one-step” analog tracer (28.0 pmo/L) and “two-step” Lisophase® (13.3 pmo/L) techniques. The discrepancy between the two measurements suggested a methodological interference due to T3-Ab in “one-step” technique, being the “two-step” methodology unaffected by the presence of such autoantibodies. T3-Ab were documented by high nonspecific binding of serum to labeled T3 (38.0% vs 4.3 ± 2.1% in controls). The clinical picture of hyperthyroidism, the qualitatively normal TSH responses to TRH and T3 suppression tests, the normal pituitary imaging and the values of some parameters of peripheral thyroid hormone action compatible with hyperthyroidism indicated that the patient was affected by pituitary resistance to thyroid hormones (PRTH). Chronic treatment with dopaminergic agent bromocriptine (7.5 mg/day) did not cause TSH secretion to be suppressed, while the administration of thyroid hormone analog TRIAC (1.4 mg/day) inhibited TSH release (from 2.4 to 0.2 mU/L). As a consequence, circulating thyroid hormone levels normalized and euthyroidism was restored. During TRIAC administration, FT3 levels, measured by “one-step” analog tracer technique, gave spuriously high values due to the methodological interference of T3-Ab (15.2 vs 4.3 pmol/L as measured by “two-step” Lisophase® technique). In conclusion, the present study indicates that a) the levels of circulating free thyroid hormones should be measured by methods unaffected by the presence of anti-iodothyronine autoantibodies in order to prevent either misdiagnosis of IST or, as in the present case, misinterpretation of the efficacy of TSH suppressive treatment, and b) it is mandatory to rule out the presence of such autoantibodies whenever IST is suspected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Gershengorn M.C., Weintraub B.D. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of “inappropriate secretion of TSH”. J. Clin. Invest. 56:633, 1975.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  2. Weintraub B.D., Gershengorn M.C., Kourides I.A., Fein H. Inappropriate secretion of thyroid-stimulating hormone. Ann. Intern. Med. 95:339,1981.

    Article  Google Scholar 

  3. Brenner-Gati L, Gershengorn M.C. Thyroid-stimulating hormone-induced hyperthy roidism. In: Imura H. (Ed.), The pituitary gland. Raven Press, New York, 1985, p. 467.

    Google Scholar 

  4. Faglia G., Beck-Peccoz P.V., Piscitelli G., Medri G. Inappropriate secretion of thyrotropin by the pituitary. Horm. Res. 26:79, 1987.

    Article  PubMed  CAS  Google Scholar 

  5. Refetoff S. Syndromes of thyroid hormone resistance. Am. J. Physiol. 243: E88, 1982.

    Google Scholar 

  6. Cooper D.S., Ladenson P.W., Nisula B.C., Dunn J.F., Chapman E.M., Ridgway E.C. Familial thyroid hormone resistance. Metabolism 31: 504, 1982.

    Article  PubMed  CAS  Google Scholar 

  7. Refetoff S., Salazar A., Smith T.J., Scherberg N.V.H. The consequences of inappropriate treatment because of failure to recognize the syndrome of pituitary and peripheral tissue resistance to thyroid hormone. Metabolism 32:822, 1983.

    Article  PubMed  CAS  Google Scholar 

  8. Pagliara A.S., Caplan R.H., Gundersen C.B., Wickus G.G., Elston A.V.C. Peripheral resistance to thyroid hormone in a family: heterogeneity of clinical presentation. J. Pediatr. 703:228,1983.

    Article  Google Scholar 

  9. Pryds O., Hadberg A., Kastrup K.W. Circulating autoantibodies to thyroid hormones: a di agnostic pitfall. Acta Pediatr. Scand. 76: 685, 1987.

    Article  CAS  Google Scholar 

  10. Wu S.E., Green W.L. Triiodothyronine (T3)-binding immunoglobulins in a euthyroid woman: effects on measurement of T3(RIA) and on T3 turnover. J. Clin. Endocrinol. Metab. 42:642, 1976.

    Article  PubMed  CAS  Google Scholar 

  11. Ginsberg J., Segal D., Herlich R.M., Walfish P.G. Inappropriate triiodothyronine (T3) and thyroxine (T4) radioimmunoassay levels secondary to circulating thyroid hormone autoantibodies. Clin. Endocrinol. (Oxf.) 8:133, 1978.

    Article  CAS  Google Scholar 

  12. Beck-Peccoz P., Romelli P.B., Faglia G. Circulating antitriiodothyronine autoantibodies in two euthyroid patients: apparent lack of interference in total T3 radioimmunoassay based on second anti body or solid phase separation techniques. J. Endocrinol. Invest. 6:333,1983.

    Article  PubMed  CAS  Google Scholar 

  13. Beck-Peccoz P., Romelli P.B., Cattaneo M.G., Faglia G., White E.L., Barlow J.W., Stockigt J.R. Evaluation of free thyroxine methods in the presence of iodothyronine-binding autoantibodies. J. Clin. Endocrinol. Metab. 53:736,1984.

    Article  Google Scholar 

  14. Konishi J., Iida Y., Kuosaka T., Ikekubo K., Nagakawa T., Torizuka K. Effect of anti-thyroxine autoantibodies on radioimmunoassay of free thyroxine in serum. Clin. Chem. 23:1389,1982.

    Google Scholar 

  15. Sakata S., Nakamura S., Miura K. Autoantibodies against thyroid hormones or iodothy- ronine. Implications in diagnosis, thyroid function, treatment and pathogenesis. Ann. Intern. Med. 103:579, 1985.

    Article  PubMed  CAS  Google Scholar 

  16. Beck-Peccoz P., Medri G., Rossi C., Romelli P.B. Circulating antibodies against iodothyronine cause spurious results in specific thyroid hormone immunoassays. J.Clin. Immunoassay 9:211, 1986. 17._EkinsR.P. Free hormones in blood: the concept and the measurement. J. Clin. Immunoassay 7:163,1984.

    CAS  Google Scholar 

  17. Greulich W.W., Pyle S. I. Radiographic atlas of skeletal development of the hand and wrist., ed. 2. Stanford University Press, Stanford, 1959.

    Google Scholar 

  18. Romelli P.B., Pennisi F., Vancheri L. Measurement of free thyroid hormones in serum by column adsorption chromatography and radioim munoassay. J. Endocrinol. Invest. 2:25,1979.

    Article  PubMed  CAS  Google Scholar 

  19. Diamandis E.P. Immunoassays with time-resolved fluorescence spectroscopy: principles and applications. Clin. Biochem. 21:139,1988.

    Article  PubMed  CAS  Google Scholar 

  20. Faglia G., Beck-Peccoz P., Ballabio M., Nava C. Excess of β-subunit of thyrotropin (TSH) in patients with idiopathic central hypothyroidism due to the se cretion of TSH with reduced biological activity. J. Clin. Endocrinol. Metab. 56:908, 1983.

    Article  PubMed  CAS  Google Scholar 

  21. Friedman M.J., Okada R.D., Ewy G.A., Hellman D.J. Left ventricular systolic and diastolic function in hy perthyroidism. Am. Heart J. 704:1303, 1982.

    Article  Google Scholar 

  22. Ooi T.C., Whitlock R.M.L., Frengley P.A., Ibbertson H.K. Systolic time intervals and ankle reflex time in patients with minimal serum TSH elevation: response to triiodothyronine therapy. Clin. Endocrinol. (Oxf.) 13: 621,1980.

    Article  CAS  Google Scholar 

  23. Beck-Peccoz P., Piscitelli G., Medri G., Ballabio M., Faglia G. Thyroid test strategy. Lancet 7:1456, 1985.

    Google Scholar 

  24. Stockigt J.R., DeGaris M., Csicsmann J., Barlow J.W., White E.L., Hurley D.M. Limitations of a new free thyroxine assay (Amerlex Free T4). Clin. Endocrinol. (Oxf.) 75:313,1981.

    Article  Google Scholar 

  25. Spanheimer R.G., Bar R.S., Hayford J.C. Hyperthyroidism caused by inappropriate thyrotropin hypersecretion: studies in patients with selective pi tuitary resistance to thyroid hormone. Arch. Intern. Med. 742:1283,1982.

    Article  Google Scholar 

  26. Beck-Peccoz P., Mariotti S., Guillausseau P.J., Medri G., Piscitelli G., Berteli A., Barbarino A., Rondena M., Chanson Ph., Pinchera A., Faglia G. Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201–995. J. Clin. Endocrinol. Metab. 63:208,1989.

    Article  Google Scholar 

  27. Beck-Peccoz P., Roncoroni R., Mariotti S., Medri G., Marcocci C., Brabant G., Forloni F., Pinchera A., Faglia G. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (1ST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic 1ST. J. Clin. Endocrinol. Metab. 71:19, 1990.

    Article  PubMed  CAS  Google Scholar 

  28. Rosier A., Litvin Y., Hage C., Gross J., Cerasi E. Familial hyperthyroidism due to inappropriate thy rotropin secretion successfully treated with tri iodothyronine. J. Clin. Endocrinol. Metab. 54:76,1982.

    Article  Google Scholar 

  29. Mariotti S., Anelli S., Bartalena L, Bechi R., Martino E., Mammoli C, Beck-Peccoz P., Pinchera A. Familial hyperthyroidism due to nonneoplastic inap propriate TSH secretion associated with sellar ab normalities. J. Endocrinol. Invest. (Suppl.1) 70:20, 1987 (Abstrat).

    Google Scholar 

  30. Beck-Peccoz P., Piscitelli G., Cattaneo M.G., Faglia G. Successful treatment of hyperthyroidism due to non neoplastic pituitary TSH hypersecretion with 3,5,3′-tri- iodothyroacetic acid (TRIAC). J. Endocrinol. Invest. 6:217,1983.

    Article  PubMed  CAS  Google Scholar 

  31. Salmela P.I., Wide L., Juustila H., Ruokonen A. Effects of thyroid hormones (T4, T3), bromocriptine and TRIAC on inappropriate TSH hypersecretion. Clin. Endocrinol. (Oxf) 28:497, 1988.

    Article  CAS  Google Scholar 

  32. Langer HJ., Leicht E., Koch B., Eber O. Familiäre, nicht-neoplastische inadäquate Thyreo-tropin-lnkretion. Dtsch. Med. Wschr, 115:813, 1990.

    Article  PubMed  CAS  Google Scholar 

  33. Kunitake J.M., Hartman N., Henson L.C., Lieberman J., Williams D.E., Wong M., Hershman J.M. 3,5,3′-triiodothyroacetic acid therapy for thyroid hor mone resistance. J. Clin. Endocrinol. Metab. 69:46,1989.

    Article  Google Scholar 

  34. Hamon P., Bovier-Lapierre M., Robert M., Peynaud D., Pugeat M., Orgiazzi J. Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-Thyroxine therapy. J. Clin. Endocrinol. Metab. 67:1089, 1988.

    Article  PubMed  CAS  Google Scholar 

  35. Dorey F., Strauch G., Gayno J.P. Thyrotoxicosis due to pituitary resistance to thyroid hormones. Successful control with D-thyroxine; a study in three patients. Clin. Endocrinol. (Oxf.) 32:221, 1990.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crinò, A., Borrelli, P., Salvatori, R. et al. Anti-iodothyronine autoantibodies in a girl with hyperthyroidism due to pituitary resistance to thyroid hormones. J Endocrinol Invest 15, 113–120 (1992). https://doi.org/10.1007/BF03348675

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348675

Key-words

Navigation